Animal models of Parkinson's disease: vertebrate genetics.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cold Spring Harbor Perspectives in Medicine

• Publication date

  2012-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1101/cshperspect.a009324PMID 22960626PMCID PMC3475398
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions.

  2011cited by this paper
• Dopaminergic Neuronal Loss, Reduced Neurite Complexity and Autophagic Abnormalities in Transgenic Mice Expressing G2019S Mutant LRRK2

  2011cited by this paper
• PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease.

  2011influential reference
• Recent advances in the genetics of Parkinson's disease.

  2011cited by this paper
• Resistance to MPTP-Neurotoxicity in α-Synuclein Knockout Mice Is Complemented by Human α-Synuclein and Associated with Increased β-Synuclein and Akt Activation

  2011cited by this paper
• The control systems structures of energy metabolism

  2010cited by this paper
• Inhibitors of Leucine Rich Repeat Kinase 2 (LRRK2) Protect Against LRRK2-Models of Parkinson’s Disease

  2010cited by this paper
• Mitochondria get a Parkin' ticket

  2010cited by this paper
• Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1

  2010cited by this paper
• Genetic animal models of Parkinson's disease.

  2010influential reference
• Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology.

  2009cited by this paper
• Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease

  2009cited by this paper
• Absence of nigral degeneration in aged parkin/DJ‐1/PINK1 triple knockout mice

  2009cited by this paper
• Parkinson Phenotype in Aged PINK1-Deficient Mice Is Accompanied by Progressive Mitochondrial Dysfunction in Absence of Neurodegeneration

  2009influential reference
• alpha-synuclein and LRRK2: partners in crime.

  2009cited by this paper
• Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress

  2008cited by this paper
• The Chaperone Activity of Heat Shock Protein 90 Is Critical for Maintaining the Stability of Leucine-Rich Repeat Kinase 2

  2008cited by this paper
• Neurodegeneration and Motor Dysfunction in a Conditional Model of Parkinson's Disease

  2008cited by this paper
• Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice

  2007cited by this paper
• Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity.

  2007cited by this paper
• DJ-1 and Parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice.

  2007cited by this paper
• Transgenic animal models of neurodegenerative diseases and their application to treatment development.

  2007influential reference
• Silencing of the Pink1 Gene Expression by Conditional RNAi Does Not Induce Dopaminergic Neuron Death in Mice

  2007cited by this paper
• MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity.

  2007influential reference
• FELASA guidelines for the production and nomenclature of transgenic rodents

  2007cited by this paper
• DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase

  2007cited by this paper
• Tetracycline-controlled genetic switches.

  2007cited by this paper
• DJ-1 and Parkin Modulate Dopamine-dependent Behavior and Inhibit MPTP-induced Nigral Dopamine Neuron Loss in Mice.

  2007influential reference
• The mouse ascending: perspectives for human-disease models

  2007cited by this paper
• Interaction of Genetic and Environmental Factors in a Drosophila Parkinsonism Model

  2007cited by this paper
• Neuronal !-Synucleinopathy with Severe Movement Disorder in Mice Expressing A 53 T Human !-Synuclein

  2007cited by this paper
• Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin

  2006cited by this paper
• Parkinson's Disease α-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death

  2006cited by this paper
• Increased sensitivity to MPTP in human alpha-synuclein A30P transgenic mice.

  2006cited by this paper
• Identification of Far Upstream Element-binding Protein-1 as an Authentic Parkin Substrate*

  2006cited by this paper
• Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death.

  2006cited by this paper
• Diagnosis and treatment of Parkinson disease: molecules to medicine.

  2006influential reference
• Accumulation of the Authentic Parkin Substrate Aminoacyl-tRNA Synthetase Cofactor, p38/JTV-1, Leads to Catecholaminergic Cell Death

  2005cited by this paper
• Mediation of cell death by poly(ADP-ribose) polymerase-1.

  2005cited by this paper
• Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1.

  2005cited by this paper
• An efficient system for tissue-specific overexpression of transgenes in podocytes in vivo.

  2005cited by this paper
• Molecular pathophysiology of Parkinson's disease.

  2005cited by this paper
• Age-dependent Motor Deficits and Dopaminergic Dysfunction in DJ-1 Null Mice*

  2005cited by this paper
• Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity

  2005cited by this paper
• The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson’s disease and originates from a common ancestor

  2005cited by this paper
• Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress.

  2005cited by this paper
• Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity.

  2005cited by this paper
• Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP.

  2004cited by this paper
• Alpha-synuclein and transgenic mouse models.

  2004cited by this paper
• Loss of locus coeruleus neurons and reduced startle in parkin null mice.

  2004influential reference
• Enhanced substantia nigra mitochondrial pathology in human α-synuclein transgenic mice after treatment with MPTP111-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  2004cited by this paper
• Nigrostriatal α-synucleinopathy induced by viral vector-mediated overexpression of human α-synuclein: A new primate model of Parkinson's disease

  2003cited by this paper
• α-Synuclein Locus Triplication Causes Parkinson's Disease

  2003cited by this paper
• Parkinson's Disease Mechanisms and Models

  2003cited by this paper
• alpha-Synuclein locus triplication causes Parkinson's disease.

  2003cited by this paper
• Why are some human disease-associated mutations fixed in mice?

  2003cited by this paper
• Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons*

  2003cited by this paper
• Part II: α-synuclein and its molecular pathophysiological role in neurodegenerative disease

  2003cited by this paper
• Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation.

  2003cited by this paper
• Genetics of Parkinson's disease: What do mutations in DJ‐1 tell us?

  2003cited by this paper
• Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease.

  2003cited by this paper
• Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse.

  2003cited by this paper
• Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice

  2002cited by this paper
• Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP

  2002cited by this paper
• Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.

  2002cited by this paper
• Initial sequencing and comparative analysis of the mouse genome

  2002cited by this paper
• Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice.

  2002cited by this paper
• α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease

  2002cited by this paper
• Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.

  2002cited by this paper
• alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.

  2002cited by this paper
• Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies.

  2002cited by this paper
• Respiration and parturition affected by conditional overexpression of the Ca2+-activated K+ channel subunit, SK3.

  2000cited by this paper
• Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.

  2000cited by this paper
• Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism.

  1999cited by this paper
• Spatio-temporally controlled site-specific somatic mutagenesis in the mouse.

  1997cited by this paper
• Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

  1997cited by this paper
• The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease

  1997cited by this paper
• α-Synuclein in Lewy bodies

  1997cited by this paper
• Alpha-synuclein in Lewy bodies.

  1997cited by this paper
• Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

  1997cited by this paper
• Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.

  1996cited by this paper
• Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

  1992cited by this paper
• Reverse genetics using transgenic mice.

  1990cited by this paper
• The new mouse genetics: altering the genome by gene targeting.

  1989cited by this paper
• The Lewy body in Parkinson's disease.

  1987cited by this paper

• Parkin–ACSL4 axis in ferroptosis regulation: a narrative review on therapeutic insights from exercise in aging cardiomyocytes

  2026cites this paper
• Dual regulation of mitochondrial fusion by Parkin–PINK1 and OMA1

  2025cites this paper
• Preclinical studies and transcriptome analysis in a model of Parkinson’s disease with dopaminergic ZNF746 expression

  2025influential citation
• Animal Models of Parkinson's Disease.

  2025cites this paper
• α-Synuclein Expression Causes Mitochondria Fragmentation and Increased Sensitivity to Oxidative Stress in the Yeast Yarrowia lipolytica

  2024cites this paper
• Experimental Parkinson Models and Green Chemistry Approach.

  2024cites this paper
• Toxin-Induced Animal Models of Parkinson's Disease.

  2024cites this paper
• In Vivo Assays for Amyloid-Related Diseases.

  2024cites this paper
• Genetically modified non-human primate models for research on neurodegenerative diseases

  2024cites this paper
• Aldh1a1 and additional markers of dopamine cell heterogeneity in substantia nigra and ventral tegmental area identified as preserved in two transgenic α-synuclein mouse models of neurodegenerative disease

  2023cites this paper
• Circuit-specific gene therapy reverses core symptoms in a primate Parkinson's disease model.

  2023cites this paper
• Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson’s disease in rodent brains

  2023cites this paper
• Of Mice and Pose: 2D Mouse Pose Estimation from Unlabelled Data and Synthetic Prior

  2023cites this paper
• Parkin exerts the tumor‐suppressive effect through targeting mitochondria

  2023cites this paper
• Modeling neurodegenerative diseases using non-human primates: advances and challenges

  2022cites this paper
• Intranasal Exposure to Low-Dose Rotenone Induced Alpha-Synuclein Accumulation and Parkinson’s Like Symptoms Without Loss of Dopaminergic Neurons

  2021cites this paper
• Molecular Network for Management of Neurodegenerative Diseases and their Translational Importance using Animal Biotechnology as a Tool in Preclinical Studies

  2021cites this paper
• Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice

  2021cites this paper
• The Female Impact in the World of Neurodegeneration

  2021cites this paper
• Parkinson's in the bone

  2021cites this paper
• Complement and Coagulation Cascades are Potentially Involved in Dopaminergic Neurodegeneration in α-Synuclein-Based Mouse Models of Parkinson's Disease.

  2021cites this paper
• Mitofusins as mitochondrial anchors and tethers.

  2020cites this paper
• Serotonin in Parkinson's disease

  2020cites this paper
• The STING pathway does not contribute to behavioural or mitochondrial phenotypes in Drosophila Pink1/parkin or mtDNA mutator models

  2020cites this paper
• Parkinson Disease

  2020cites this paper
• Translocator protein 18 ligand Emapunil protects against neurodegeneration in the MPTP mouse model of Parkinsonism

  2020cites this paper
• The Potential of Distinct Species of Non-Human Model Organisms for Research of Neurodegenerative Diseases

  2020cites this paper
• Biochemical Markers in Parkinson's Disease

  2020cites this paper
• Stem Cell-Based Therapies for Parkinson Disease

  2020cites this paper
• Neuronal degeneration and cognitive impairment can be prevented via the normalization of mitochondrial dynamics.

  2020cites this paper
• Characterization of a Cul9–Parkin double knockout mouse model for Parkinson’s disease

  2020cites this paper
• Endosomal dysfunction in iPSC-derived neural cells from Parkinson’s disease patients with VPS35 D620N

  2020cites this paper
• Functional genomics, genetic risk profiling and cell phenotypes in neurodegenerative disease

  2020cites this paper
• Synuclein Deficiency Results in Age-Related Respiratory and Cardiovascular Dysfunctions in Mice

  2020cites this paper
• Parallel-Channel Electrotaxis and Neuron Screening of Caenorhabditis elegans

  2020cites this paper
• Novel Nasal Epithelial Cell Markers of Parkinson’s Disease Identified Using Cells Treated with α-Synuclein Preformed Fibrils

  2020cites this paper
• Genetically Engineered Biomaterials

  2020cites this paper
• Animal Models for Parkinson’s Disease Research: Trends in the 2000s

  2019cites this paper
• Evolving and Expanding the Roles of Mitophagy as a Homeostatic and Pathogenic Process.

  2019cites this paper
• Acquired Expression of Mutant Mitofusin 2 Causes Progressive Neurodegeneration and Abnormal Behavior

  2019cites this paper
• Dopamine neuronal protection in the mouse Substantia nigra by GHSR is independent of electric activity

  2019cites this paper
• Immune Signaling in Neurodegeneration.

  2019cites this paper
• The STING pathway does not contribute to Pink1/parkin phenotypes in Drosophila

  2019cites this paper
• Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity

  2019cites this paper
• Cell-Based Screen Using Amyloid Mimic β23 Expression Identifies Peucedanocoumarin III as a Novel Inhibitor of α-Synuclein and Huntingtin Aggregates

  2019cites this paper
• Studying Parkinson's disease using Caenorhabditis elegans models in microfluidic devices.

  2019cites this paper
• Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson's disease.

  2019cites this paper
• МОДЕЛИРОВАНИЕ БОЛЕЗНИ ПАРКИНСОНА С ПОМОЩЬЮ ЭКЗОГЕННЫХ НЕЙРОТОКСИНОВ (ОБЗОР ЛИТЕРАТУРЫ)

  2019cites this paper
• Evolving Concepts of Mitochondrial Dynamics.

  2019cites this paper
• MODELING OF PARKINSON’S DISEASE USING ENVIRONMENTAL NEUROTOXINS (REVIEW)

  2019cites this paper
• Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson’s Disease in Rodents

  2018cites this paper
• Atlas of the Striatum and Globus Pallidus in the Tree Shrew: Comparison with Rat and Mouse

  2018cites this paper
• CRISPR/Cas9-Mediated Generation of Guangxi Bama Minipigs Harboring Three Mutations in α-Synuclein Causing Parkinson’s Disease

  2018cites this paper
• Animal models of neurodegenerative diseases

  2018cites this paper
• A Motor Phenotype of ɑ-Synuclein-Mediated Dopaminergic Neuron Dysfunction in a C. elegans Model

  2018cites this paper
• Parkinson’s disease-associated protein Parkin: an unusual player in cancer

  2018cites this paper
• Study of the pair Netrin-1/DCC in Parkinson's diseas

  2018cites this paper
• New Developments in Genetic rat models of Parkinson's Disease

  2018cites this paper
• Proliferation and differentiation of human fetal brain neural stem cells in vitro

  2018cites this paper
• Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease

  2018cites this paper
• Basal mitophagy is widespread in Drosophila but minimally affected by loss of Pink1 or parkin

  2018cites this paper
• Misfolded proteins affect synaptic plasticity and network activity

  2017cites this paper
• E46K α-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregation

  2017cites this paper
• Conserved regulators of cognitive aging: From worms to humans

  2017cites this paper
• Induced Pluripotent Stem Cell Therapy and Safety Concerns in Age-Related Chronic Neurodegenerative Diseases

  2017cites this paper
• CRISPR-Cas9 Mediated Telomere Removal Leads to Mitochondrial Stress and Protein Aggregation

  2017cites this paper
• Disorders of the Nervous System Overexpression of Parkinson ’ s Disease-Associated Mutation LRRK 2 G 2019 S in Mouse Forebrain Induces Behavioral Deficits and-Synuclein Pathology

  2017cites this paper
• Role of aromatase and radial glial cells in neurotoxin-induced dopamine neuron degeneration and regeneration.

  2017cites this paper
• Models of LRRK2-Associated Parkinson's Disease.

  2017cites this paper
• The Diversity and Complexity of Parkin Function

  2017cites this paper
• Beyond Mitophagy: The Diversity and Complexity of Parkin Function.

  2017cites this paper
• Neurodegenerative Disease Transmission and Transgenesis in Mice.

  2017cites this paper
• Neonatal C57BL/6J and parkin mice respond differently following developmental manganese exposure: Result of a high dose pilot study

  2017cites this paper
• Yeast models of Parkinson's disease-associated molecular pathologies.

  2017cites this paper
• Effets des acides gras polyinsaturés oméga-3 dans deux modèles murins de maladie de Parkinson

  2017cites this paper
• Animal Models for the Study of Human Neurodegenerative Diseases

  2017cites this paper
• Mitochondriale Dysfunktion bei Parkin-Mausmodellen des Morbus Parkinson

  2017cites this paper
• Effect of Jack Bean Supplement on the Response of Rabbits to In-Vivo Experimental Cystitis

  2017cites this paper
• Alpha-synucleinopathies.

  2017cites this paper
• Overexpression of Parkinson’s Disease-Associated Mutation LRRK2 G2019S in Mouse Forebrain Induces Behavioral Deficits and α-Synuclein Pathology

  2017cites this paper
• Novel Insights into NeuN: from Neuronal Marker to Splicing Regulator

  2016cites this paper
• Therapeutic Strategies for Neuropathic Pain: Potential Application of Pharmacosynthetics and Optogenetics

  2016cites this paper
• Early Degeneration of Both Dopaminergic and Serotonergic Axons – A Common Mechanism in Parkinson’s Disease

  2016cites this paper
• Central Parkin: The evolving role of Parkin in the heart.

  2016cites this paper
• Adult Conditional Knockout of PGC-1α Leads to Loss of Dopamine Neurons

  2016cites this paper
• Impairment of PARK14-dependent Ca2+ signalling is a novel determinant of Parkinson's disease

  2016cites this paper
• α-Synuclein-Based Animal Models of Parkinson's Disease: Challenges and Opportunities in a New Era.

  2016cites this paper
• Parkin-dependent mitophagy in the heart.

  2016cites this paper
• Activation of tyrosine kinase c-Abl contributes to α-synuclein-induced neurodegeneration.

  2016cites this paper
• Retrograde Axonal Degeneration in Parkinson Disease

  2016cites this paper
• CRISPR/Cas9: a powerful genetic engineering tool for establishing large animal models of neurodegenerative diseases

  2015cites this paper
• Potential of Cellular and Animal Models Based on a Prion-Like Propagation of α-Synuclein for Assessing Antiparkinson Agents

  2015cites this paper
• VPS35 Deficiency or Mutation Causes Dopaminergic Neuronal Loss by Impairing Mitochondrial Fusion and Function.

  2015influential citation
• Large Animal Models of Huntington's Disease.

  2015cites this paper
• When rejuvenation is a problem: challenges of modeling late-onset neurodegenerative disease

  2015cites this paper
• Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.

  2015cites this paper
• Chapter 5 – Parkinson Disease

  2015cites this paper
• VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for α-Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease

  2015cites this paper
• Parkin-mediated mitophagy directs perinatal cardiac metabolic maturation in mice

  2015cites this paper
• Topographic organization of the human and non-human primate subthalamic nucleus

  2015cites this paper